ASHLEIGH CATES: Open Payments
NPI 1972161818 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 27 payments from 11 companies in 2025. Trend: 2023 $146 · 2024 $29 · 2025 $555
Food & beverage: $537Education: $18
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 8 | $137 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| GENZYME CORPORATION | 2 | $67 |
| Novo Nordisk Inc | 4 | $63 |
| Calliditas Therapeutics US Inc. | 2 | $55 |
| Mallinckrodt Hospital Products Inc. | 2 | $38 |
| CVRx, Inc. | 1 | $24 |
| Bard Peripheral Vascular, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Medtronic, Inc. | 1 | $16 |
Products named: JYNARQUE, FABRAZYME, Ozempic, TARPEYO, VOYXACT, Barostim Neo System, COVERA, TERLIVAZ.
Industry payments across TN — which companies pay providers there.
